Zealand Pharma A/s Stock
€109.60
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Zealand Pharma A/s | -2.590% | -8.438% | -4.944% | 171.556% | 116.174% | 301.465% | - |
Saniona AB | -3.300% | -6.513% | 10.407% | -28.235% | 10.407% | -72.929% | -83.661% |
Immunic Inc. | 0.890% | -16.223% | 10.103% | -0.789% | -3.217% | -83.335% | -85.847% |
Actinium Pharmaceuticals Inc. | 1.120% | -0.554% | -8.437% | -72.593% | -64.226% | -80.400% | -74.623% |
News
Better Buy: Celsius Stock at a 52-Week Low or a 50/50 Split of Dividend Kings Pepsi and Coca-Cola?
The beverage industry doesn't get disrupted easily. Sure, new products may catch on as fads. But it's rare for a brand to achieve global recognition.
Red Bull pioneered the energy drink industry and
Prediction: This Hypergrowth Space Stock Will Be Worth More Than SpaceX In 10 Years
SpaceX has been a remarkable success over the last 15 years. It brought the space flight industry in the United States -- really, around the world -- back to life and inspired plenty of copycats
This Rising Biotech Is a Fantastic Weight-Loss Stock to Buy Now
As we all know, the weight-loss drug revolution is making a lot of companies rich, and the party's just getting started. Weight-loss drug developers like the Danish biotech Zealand Pharma (OTC: